PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 10, 2007 Subscribe to this News Feed    
 

LegalView Announces Launch of New Practice Area Focusing on Pressing Fentora Issues

As a result of new concerns regarding incorrect prescriptions of the powerful opioid Fentora, LegalView creates information portal for those concerned about the drug's properties and effects.

Denver, CO (PRWEB) October 10, 2007 -- LegalView.com, a complete source for everything legal on the web, would like to announce that readers can now find important information regarding a prescription drugs that have been shown to be potentially hazardous to patients, Fentora. While the drug itself is not dangerous, the federal Food and Drug Administration (FDA) recently released a Public Health Advisory on September 26, 2007 concerning a growing trend of improper dosages and even worse, patients being prescribed the medication for whom it was never intended, with the potential of causing serious life threatening side effects. By consulting LegalView's Fentora Information portal, located at http://fentora.legalview.com/, readers can gain valuable information about the important safety considerations involved with taking this drug.

Fentora is a pain-relief medication that contains Fentanyl Buccal. This medication is used to treat moderate-to-severe sudden (breakthrough) cancer pain in those patients who may have become opioid-tolerant. In September 2007, the FDA urged Cephalon, the manufacturer of Fentora, issued two "Dear Healthcare Professional Letters" to inform prescribers and other healthcare providers of important safety information regarding Fentora. Fentora is indicated only for the management of breakthrough pain in patients with cancer who are already receiving, and who are tolerant to, opioid therapy for their underlying persistent cancer pain. Serious adverse events, including deaths, have occurred in patients treated with Fentora. These deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients), improper dosing, and/or improper product substitution. The healthcare professional letters provide key points regarding appropriate patient selection and proper dosing and administration of Fentora to reduce the risk of respiratory depression and death. Anyone who has concerns about taking Fentora can consult the LegalView Fentora resource to better understand the drug's potential dangers, or to be put in touch with a Fentora attorney.

The Fentora portal is just part of LegalView's collection of free, comprehensive information on the legal issues important to Americans. Readers may also be interested in news, statistics, research and legal information regarding a mesothelioma law firm, a brain injury attorney, a birth injury lawyer or an auto accident attorney. On all of these sites and others in LegalView's family of free informational Web portals, visitors can find original articles explaining the issue in plain language; links to legal resources; glossaries of medical terms, where appropriate; government warnings and releases; and much more. And if you believe you may need legal counsel on these topics or others, LegalView offers visitors a way to connect with expert attorneys in their area who can evaluate their case for no charge.

LegalView.com is a free service to the public, brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of highly respected national law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's distinguished sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.legalview.com/.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RmFsdS1Db3VwLUhvcnItVGhpci1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Peter Kent
LegalView.com
720-771-3246
Email us Here
Alan Haburchak
LegalView.com
720-226-6613
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move